Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.
Leukemia cutis (LC) and eosinophilic dermatosis of hematologic malignancy (EDHM) are rare cutaneous manifestations of hematologic malignancies. Various therapeutic options have been reported, with largely underwhelming responses. We present a patient with chronic lymphocytic leukemia (CLL) with concomitant LC and EDHM who was treated with dupilumab.
Jin, Annie; Pousti, Bobak T.; Savage, Kevin T.; Mollanazar, Nicholas K.; Lee, Jason B.; and Hsu, Sylvia, "Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia." (2019). Department of Dermatology and Cutaneous Biology Faculty Papers. Paper 114.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
This article has been peer reviewed. It is the author’s final published version in JAAD Case Reports, Volume 5, Issue 9, September 2019, Pages 815-817.
The published version is available at https://doi.org/10.1016/j.jdcr.2019.07.026. Copyright © Jin et al.